HHS — Harte Hanks Income Statement
0.000.00%
- $17.57m
- $12.61m
- $159.57m
Annual income statement for Harte Hanks, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 195 | 206 | 191 | 185 | 160 |
| Cost of Revenue | |||||
| Gross Profit | 34.4 | 35.8 | 34 | 34.8 | 28.8 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 177 | 191 | 188 | 221 | 159 |
| Operating Profit | 17.6 | 15.1 | 3.36 | -35.4 | 0.386 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 16.3 | 19.3 | -1.92 | -37.9 | -1.01 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 15 | 36.8 | -1.57 | -30.3 | -0.811 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 15 | 36.8 | -1.57 | -30.3 | -0.811 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 12.6 | 35.4 | -1.57 | -30.3 | -0.811 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.29 | 4.75 | 0.291 | -0.315 | 0.047 |